Nigel McCracken, chief operating officer, Virax Biolabs, discusses new findings that reveal altered cytokine activity and ...

Nigel McCracken, chief operating officer, Virax Biolabs, discusses results from new data on the role of T cell dysfunction in ...

However, T cell exhaustion is a problem in the treatment of cancer, as therapeutic measures may no longer be effective. Until now, it was assumed that the body only produces such T cells in severe ...

However, T cell exhaustion is a problem in the treatment of cancer, as therapeutic measures may no longer be effective. The team deduces from the discovery that the body assembles a range of ...

Immune cells deliver packages of telomeres to T cells, helping them retain their virus-fighting function over time ... Meet the low-cost standard for hypoxic and physioxic environment cell culture ...

However, T cell exhaustion is a problem in the treatment of cancer, as therapeutic measures may no longer be effective. Until now, it was assumed that the body only produces such T cells in severe ...

multiplex T cell exhaustion, and bead-based measurement of secreted cytokines, all in the same assay. Quantify activation markers, cell count, cell membrane integrity, secreted pro-inflammatory ...